Skip to main content

New Director Appointed to Lead the University of Maryland Children's Hospital

March 15, 2017

Steven J. Czinn, MD

Steven Czinn, MD, Appointed as Director to Enhance Multidisciplinary Pediatric Patient Care and Research

University of Maryland Medical Center (UMMC) President and Chief Executive Officer Mohan Suntha, MD, MBA and University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Steven J. Czinn, MD, The Drs. Rouben and Violet Jiji Endowed Professor of Pediatrics and Chair of the Department of Pediatrics at the University of Maryland School of Medicine, has been appointed to the role of Director of the University of Maryland Children’s Hospital (UMCH). In this new capacity, he will help steer the performance, success, multidisciplinary collaboration and optimization of research and patient care at UMCH, part of the University of Maryland Medical Center (UMMC).

This newly-created position was designed to help advance a strategic plan and vision for the Children’s Hospital, with optimal patient outcomes as the central tenet. Dr. Czinn, a nationally recognized pediatric gastroenterologist who has been a part of the University of Maryland family since 2006 is charged with charting a course for the future that takes the Children’s Hospital to the next level, and improves upon the excellent care provided to its youngest patients. Among his new responsibilities include engaging across all internal stakeholder groups (leadership, faculty, nursing, patient care teams and partners throughout the UMMS enterprise) to establish and advance priorities; working across clinical departments to foster a multidisciplinary approach for the care of children; strengthening collaborative clinical research across pediatric subspecialties; helping spearhead philanthropic initiatives in support of the Children’s Hospital; and leading efforts to promote performance on quality standards and patient experience metrics.

“The University of Maryland Children’s Hospital is a remarkable institution, and a hallmark of excellence at the University of Maryland Medical Center,” said Dr. Suntha, who is also The Marlene and Stewart Greenebaum Professor of Radiation Oncology at the University of Maryland School of Medicine. “Under Dr. Czinn’s leadership, the Children’s Hospital provides care for a broad range of patients, from the tiniest, most fragile newborns in the Drs. Rouben and Violet Jiji Neonatal Intensive Care Unit, to teens with complex medical needs. All of us look forward to seeing the fruits of the enhanced collaboration across the organization.”

Dean Reece, who is also Vice President for Medical Affairs at the University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor at the University of Maryland School of Medicine, added: “Our leading pediatric clinical research programs are shaping the future of medical care for young patients across the region, nation and world. Under Dr. Czinn’s augmented leadership role, we will advance our expertise as he steers the Children’s Hospital to new and impressive heights as a national leader in pediatric subspecialty research and patient care.”

Dr. Czinn is known for innovative treatments for children with chronic gastric and intestinal disorders. His areas of interest include mucosal immunology, Helicobacter pylori infections and the gut microbiome. In 2010, Dr. Czinn helped develop guidelines to diagnose and manage food allergies for the National Institute of Allergy and Infectious Diseases. He also has lectured on the differences between children and adults with irritable bowel disease. Most recently, he was asked to update the Children’s Digestive Health Foundation’s educational slide set on Pediatric Gastroesophageal Reflux Disease (GERD).

From 2009 to 2013, Dr. Czinn was a scientific reviewer for the National Institutes of Health (NIH) in the area of gastrointestinal mucosal pathobiology studies. He is the lead author or co-author on more than 100 peer-reviewed publications and has served as an associate editor of the American Journal of Gastroenterology since 2003. He currently serves as an associate editor of both the Journal of Pediatric Gastroenterology and Pediatric Research.

About the University of Maryland Children’s Hospital

The University of Maryland Children’s Hospital is recognized throughout Maryland and the mid-Atlantic region as a resource for critically and chronically ill children. UMCH physicians and staff excel in combining state-of-the-art medicine with family-centered care. More than 100 physicians specialize in understanding how to treat conditions and diseases in children, including congenital heart conditions, asthma, epilepsy and gastrointestinal disorders. The Drs. Rouben and Violent Jiji Neonatal Intensive Care Unit provides the highest level of care to the tiniest newborns. To learn more about the University of Maryland Children's Hospital, please visit

About the University of Maryland Medical Center

The University of Maryland Medical Center (UMMC) is comprised of two hospitals in Baltimore: an 800-bed teaching hospital – the flagship institution of the 12-hospital University of Maryland Medical System (UMMS) – and a 200-bed community teaching hospital, UMMC Midtown Campus. UMMC is a national and regional referral center for trauma, cancer care, neurocare, cardiac care, diabetes and endocrinology, women’s and children’s health, and has one of the largest solid organ transplant programs in the country. All physicians on staff at the flagship hospital are faculty physicians of the University of Maryland School of Medicine. At UMMC Midtown Campus, faculty physicians work alongside community physicians to provide patients with the highest quality care. UMMC Midtown Campus was founded in 1881 and is located one mile away from the University Campus hospital. For more information, visit

About the University of Maryland School of Medicine

The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world. Visit us at

Learn More

• Steven J. Czinn, MD

• University of Maryland Children's Hospital

• Department of Pediatrics


Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Monday, November 21, 2022

    UM School of Medicine Empowers Faculty Members Through Recently Founded Academy for Career Development

    Within a year of the launch of the Medical Education Leadership Academy (MELA) at the University of Maryland School of Medicine (UMSOM), faculty members from across the School’s various divisions are expressing an overwhelmingly positive response to the Academy’s mission of creating an environment that fosters career development of a diverse community of nationally recognized leaders in medical education.

    Tuesday, August 30, 2022

    $800K Donation Will Fund New Discoveries and Treatments for ALS

    The University of Maryland School of Medicine (UMSOM) will receive an $800,000 donation to be used by the University of Maryland Brain and Tissue Bank to advance research into the treatment and cure of Amyotrophic Lateral Sclerosis (ALS), commonly referred to as Lou Gehrig’s Disease.

    Friday, December 18, 2020

    Low-Income Preschoolers Exposed to Nurturing Care Have Higher IQ Scores During Their Teen Years, Landmark Study Finds

    Preschoolers living in impoverished communities who have access to a nurturing home environment have significantly higher intelligence quotient (IQ) scores in adolescence compared to those raised without nurturing care. That is the finding of a new international study conducted by University of Maryland School of Medicine (UMSOM) researchers, which examined data from more than 1,600 children who were followed from birth through their teenage years. Results were published this week in The Lancet Child & Adolescent Health journal.

    Monday, June 17, 2019

    Primate Study Finds New Evidence that Growth Factor Plays Key Role in Maintaining Healthy Pregnancy

    About 1 in 10 pregnant women experience placenta abnormalities that lead to life-threatening preeclampsia (hypertension), preterm labor and fetal growth problems, but finding effective treatments to effectively prevent or reverse these conditions has so far been elusive. A new research finding from University of Maryland School of Medicine (UMSOM) researchers, published in the June issue of the journal Endocrinology, could have important implications for developing novel treatments to prevent placental abnormalities.

    Monday, September 11, 2017

    Research Identifies Causes and Possible Treatments for Deadly Diseases Affecting Children in Developing Countries

    University of Maryland School of Medicine Researchers Explore How to Prevent Diarrheal Diseases, a Leading Cause of Death in Young Children in Sub-Saharan Africa and South Asia